Use of cognitive enhancers for mild cognitive impairment: protocol for a systematic review and network meta-analysis

BACKGROUND: Elderly individuals who have memory problems without significant limitations in activities of daily living are often diagnosed as having mild cognitive impairment (MCI). Some of these individuals progress to dementia. Several cognitive enhancers (for example donepezil, galantamine, rivas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C, Soobiah, Charlene, Lillie, Erin, Perrier, Laure, Chen, Maggie H, Hemmelgarn, Brenda, Majumdar, Sumit R, Straus, Sharon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434042/
https://www.ncbi.nlm.nih.gov/pubmed/22647316
http://dx.doi.org/10.1186/2046-4053-1-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434042/
https://www.ncbi.nlm.nih.gov/pubmed/22647316
http://dx.doi.org/10.1186/2046-4053-1-25

Ejemplares similares